Drugmaker backpedals on specialty status for COVID-19 drug

Dh logo

Local coronavirus coverage

Southwest Life

Drugmaker backpedals on specialty status for COVID-19 drug

Gilead Sciences said Wednesday, March 25, 2020, it will give up the specialty status it received days earlier for its COVID-19 drug amid public outrage that the company was seeking to boost the profits of its treatment.

Drugmaker backpedals on specialty status for COVID-19 drug

Gilead Sciences said Wednesday, March 25, 2020, it will give up the specialty status it received days earlier for its COVID-19 drug amid public outrage that the company was seeking to boost the profits of its treatment.
Listen
Loading the English audio player...
Escuchar en Español:
Loading the Español audio player...
click here to add your event
Area Events